Bethany and Heaven

Resolve Gut Dysbiosis and Improve Health Outcomes in NICU Infants

New research shows significant improvement in gut dysbiosis and enteric inflammation in neonates fed Evivo

New research provides clinical evidence that Evivo (activated B. infantis EVC001) resolves gut dysbiosis and improves clinical outcomes in neonates. NICU patients fed Evivo had significantly reduced intestinal inflammation and nosocomially acquired antibiotic resistance, along with decreased antibiotic exposure and lower incidence of diaper rash.

In this webinar learn:

  • The clinical consequences of gut dysbiosis in the NICU
  • The clinical outcomes of feeding activated B. infantis EVC001 to neonates
  • How to change the infant gut microbiome to resolve gut dysbiosis
  • How to implement probiotic feeding as a Standard of Care in your NICU


Webinar airs on April 22 at 7 am and 12 pm PST and April 27 at 9 am and 12:30 pm PST.
Evivo with MCT Oil

Get your patients started

Evivo with activated B. infantis EVC001 is the first and only baby probiotic clinically proven to substantially and persistently transform the infant gut microbiome.